| Title |
The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
|
|---|---|
| Published in |
BMC Infectious Diseases, December 2011
|
| DOI | 10.1186/1471-2334-11-356 |
| Pubmed ID | |
| Authors |
Magnus Gisslén, Richard W Price, Staffan Nilsson |
| Abstract |
A substantial prevalence of mild neurocognitive disorders has been reported in HIV, also in patients treated with combination antiretroviral therapy (cART). This includes a new disorder that has been termed asymptomatic neurocognitive impairment (ANI). |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 60% |
| Unknown | 2 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 1% |
| Netherlands | 1 | <1% |
| South Africa | 1 | <1% |
| India | 1 | <1% |
| United Kingdom | 1 | <1% |
| Argentina | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 166 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 29 | 17% |
| Student > Ph. D. Student | 25 | 14% |
| Researcher | 18 | 10% |
| Student > Bachelor | 17 | 10% |
| Student > Doctoral Student | 16 | 9% |
| Other | 31 | 18% |
| Unknown | 38 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 58 | 33% |
| Psychology | 26 | 15% |
| Agricultural and Biological Sciences | 11 | 6% |
| Neuroscience | 10 | 6% |
| Nursing and Health Professions | 5 | 3% |
| Other | 24 | 14% |
| Unknown | 40 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2012.
All research outputs
#13,753,838
of 23,317,888 outputs
Outputs from BMC Infectious Diseases
#3,457
of 7,804 outputs
Outputs of similar age
#149,315
of 246,345 outputs
Outputs of similar age from BMC Infectious Diseases
#35
of 75 outputs
Altmetric has tracked 23,317,888 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,804 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,345 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.